Navigation Links
Pathway That Degrades Holiday Turkey Fuels Metastasis of Triple Negative Breast Cancer

(PRWEB) December 10, 2014

A University of Colorado Cancer Center study being presented at the San Antonio Breast Cancer Symposium shows that triple negative breast cancer cells process tryptophan to promote survival while traveling through the body in order to seed new tumor sites.

"I'm not saying that people with metastatic breast cancer shouldn't eat turkey during the holidays, but triple-negative breast cancer appears to have found a way to process tryptophan more quickly, equipping cancer cells to survive while in circulation, which allows them to metastasize," says Thomas Rogers, the paper's first author and PhD candidate in the laboratory of CU Cancer Center investigator, Jennifer Richer, PhD.

When healthy cells become detached from the foundation on which they grow, they are programmed to undergo cell death through a process known as anoikis ("without a home" in Greek). This means that in order to metastasize, cancer cells have to evade anoikis - they have to survive while in suspension, unattached from a foundation. The current study used a gene array to discover which genes were upregulated in triple negative breast cancer cells that were able to grow in suspension compared with cells that were still attached to a substrate.

"Basically, we asked what is different in cells that are able to survive being detached," Rogers says.

Many of the gene expression changes in the triple negative breast cancer cells that had learned to survive detachment were in a single metabolic pathway - the kynurenine pathway, which is responsible for degrading the essential amino acid tryptophan. The faster the kynurenine pathway, the faster tryptophan is degraded. Controlling the speed of the kynurenine pathway is the enzyme TDO2 - which happened to be the most upregulated gene in detached compared to attached triple-negative breast cancer cells.

In other words, it may be that cancer cells over-express TDO2, which speeds up the whole kynurenine pathway, and degrades more tryptophan - all of which helps these cells to escape anoikis, which allows them to survive long enough to pick up roots and move to other places in the body.

"When a cancer cell detaches and cranks up this catabolic pathway, it can metabolize tryptophan faster and promote survival," Rogers says.

Currently, drugs targeting other enzymes in the complex chain of the kynurenine pathway are already in clinical trials. For example the drug indoximod by New Link Genetics is being tested in combination with chemotherapy against metastatic breast cancer ( number NCT01792050). This drug adjusts features within the pathway to help the body's immune system more effectively target cancer cells.

"We hope that looking at other targets in this pathway could create a more effective therapy," Rogers says. "Indoximod or other compounds like it could be used in combination to not only boost the immune system to target free-floating cancer cells, but also to re-sensitize cancer cells to the programmed cell death of anoikis."

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Decades-old conclusion about energy-making pathway of cyanobacteria is corrected
2. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
3. More evidence for longevity pathway
4. Alliance for Safe Biologic Medicines Chairman Urges FDA to Ensure that Patient Safety is the Cornerstone of Biosimilar Pathway
5. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
6. Merrimack Pharmaceuticals To Present Preliminary Clinical Data For Novel Therapies Targeting Molecular Pathways In Advanced Cancers
7. Leuven research opens new pathway for the treatment of Alzheimers disease
8. Pathway BioLogic is Chosen by Easy Gardener to Formulate the U.S.’s First Microbial Enhanced Natural Water Soluble Plant Food
9. New study validates longevity pathway
10. Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
11. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
Post Your Comments:
(Date:7/17/2019)... ... July 15, 2019 , ... CRISPR is often thought ... certain trait can be removed, replaced, or edited, but Yiping Qi, assistant professor in ... these traditional applications in his latest publication in Nature Plants. In this comprehensive review, ...
(Date:7/9/2019)... ... July 08, 2019 , ... ... SmartLight Indicator was recognized as the 2019 Innovative Product of the Year which ... prestigious awards were during Sensors Expo & Conference 2019, held this ...
(Date:6/12/2019)... ... June 12, 2019 , ... Leak Detection Associates (LDA), ... Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is excited to announce that ... grant exclusive rights for Zillion to represent LDA in all of China. ...
(Date:6/11/2019)... ... 11, 2019 , ... Veterinary Regenerative Medicine company, VetStem ... announced that their GMP facility for cell production is now approved by the ... is an important milestone for VetStem as it expands into contract cell manufacturing ...
Breaking Biology Technology:
(Date:8/6/2019)... ... August 05, 2019 , ... ... announce its attendance at the Microscopy & Microanalysis 2019 Meeting ( M&M 2019 ... Oregon Convention Center. , The Microscopy & Microanalysis Meeting, organized by the Microscopy ...
(Date:8/4/2019)... ... August 02, 2019 , ... Bioclinica, a leading provider of ... development of medical therapies, announced today that Michael O’Neal, M.D., Chief Medical Officer, ... “100 Most Inspiring People in the Life-Sciences Industry.” Dr. O’Neal was recognized ...
(Date:8/1/2019)... ... July 30, 2019 , ... Keck Graduate ... and Joy Rathmann Professor in Bioprocessing and Director of the Amgen Bioprocessing Center, ... life sciences industry and possesses more than 25 years of global experience in ...
Breaking Biology News(10 mins):